WORMENTEL-222 is a Fenbendazole 222 mg antiparasitic tablet formulated for deworming applications in professional, veterinary, and supervised experimental-use settings. It is positioned as a broad-spectrum anthelmintic for the treatment of parasitic worm infections, making it relevant for buyers sourcing antiparasitic medicines through wholesale and bulk order channels. Each unit contains Fenbendazole 222 mg, a well-known active ingredient used against intestinal worm infestations. The formulation is indicated for roundworms, hookworms, whipworms, and tapeworms, supporting use cases where broad parasite coverage is required. For procurement teams, this makes the product suitable for inventory stocking in healthcare and animal-health supply chains where export-ready antiparasitic products are needed. Manufactured by Kachhela Medex Pvt. Ltd., the product is offered as a factory direct supply item with OEM and bulk purchase potential for distribution partners. The minimum order quantity is 1 box, which is useful for pharmacies, wholesalers, research buyers, and medical trade suppliers evaluating demand before scaling. Its market relevance extends to research and experimental oncology applications listed in the source data, specifically noted as off-label use and intended only under supervision. As a medicine in the anti-infective/antiparasitic category, WORMENTEL-222 is best suited for B2B buyers looking for a specific fenbendazole strength rather than a generic deworming alternative. Buyers should confirm clinical, veterinary, and regulatory requirements before purchase, especially for supervised or experimental use cases. For wholesale procurement, the product offers a clear combination of active ingredient, defined dosage strength, and manufacturer identification that supports traceability in the supply chain.

*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.